Cullen/Frost Bankers, Inc. Astrazeneca PLC Transaction History

Cullen/Frost Bankers, Inc.

$7.21 Billion
Q4 2024

A detailed history of Cullen/Frost Bankers, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 164,671 shares of AZN stock, worth $12.5 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

164,671

Previous 152,800 7.77%

Holding current value

$12.5 Million

Previous $11.9 Million 9.38%

% of portfolio

0.15%

Previous 0.16%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$63.2 - $79.58 $750,247 - $944,694	11,871 Added 7.77%	164,671 $10.8 Million
Q3 2024 Nov 06, 2024	SELL	$76.67 - $87.62 $454,729 - $519,674	-5,931 Reduced 3.74%	152,800 $11.9 Million
Q2 2024 Aug 05, 2024	SELL	$66.81 - $80.83 $341,599 - $413,283	-5,113 Reduced 3.12%	158,731 $12.4 Million
Q1 2024 May 10, 2024	SELL	$61.03 - $69.57 $177,231 - $202,031	-2,904 Reduced 1.74%	163,844 $11.1 Million
Q4 2023 Feb 06, 2024	SELL	$61.89 - $69.28 $101,066 - $113,134	-1,633 Reduced 0.97%	166,748 $11.2 Million
Q3 2023 Nov 02, 2023	SELL	$64.85 - $71.7 $300,255 - $331,971	-4,630 Reduced 2.68%	168,381 $11.4 Million
Q2 2023 Aug 04, 2023	SELL	$69.91 - $75.81 $499,996 - $542,193	-7,152 Reduced 3.97%	173,011 $12.4 Million
Q1 2023 May 05, 2023	SELL	$63.15 - $71.6 $298,510 - $338,453	-4,727 Reduced 2.56%	180,163 $12.5 Million
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $4.46 Million - $5.79 Million	82,236 Added 80.11%	184,890 $12.5 Million
Q3 2022 Nov 07, 2022	BUY	$53.02 - $135.75 $254,071 - $650,514	4,792 Added 4.9%	102,654 $5.63 Million
Q2 2022 Aug 05, 2022	BUY	$59.26 - $71.14 $307,974 - $369,714	5,197 Added 5.61%	97,862 $6.47 Million
Q1 2022 May 09, 2022	SELL	$55.72 - $67.12 $4,513 - $5,436	-81 Reduced 0.09%	92,665 $6.15 Million
Q4 2021 Feb 07, 2022	SELL	$54.02 - $63.83 $395,696 - $467,554	-7,325 Reduced 7.32%	92,746 $5.4 Million
Q3 2021 Nov 04, 2021	SELL	$55.56 - $60.79 $2.39 Million - $2.62 Million	-43,075 Reduced 30.09%	100,071 $6.01 Million
Q2 2021 Aug 05, 2021	SELL	$48.42 - $60.18 $1.98 Million - $2.46 Million	-40,823 Reduced 22.19%	143,146 $8.57 Million
Q1 2021 May 05, 2021	SELL	$47.16 - $54.44 $2.12 Million - $2.44 Million	-44,871 Reduced 19.61%	183,969 $9.15 Million
Q4 2020 Feb 08, 2021	BUY	$48.52 - $58.02 $309,169 - $369,703	6,372 Added 2.86%	228,840 $11.4 Million
Q3 2020 Nov 05, 2020	SELL	$53.07 - $61.1 $310,512 - $357,496	-5,851 Reduced 2.56%	222,468 $12.2 Million
Q2 2020 Aug 05, 2020	SELL	$43.1 - $55.31 $38,876 - $49,889	-902 Reduced 0.39%	228,319 $12.1 Million
Q1 2020 May 01, 2020	SELL	$37.79 - $51.33 $166,842 - $226,621	-4,415 Reduced 1.89%	229,221 $10.2 Million
Q4 2019 Feb 06, 2020	SELL	$42.46 - $50.46 $2.01 Million - $2.39 Million	-47,360 Reduced 16.85%	233,636 $11.6 Million
Q3 2019 Nov 01, 2019	BUY	$40.12 - $45.47 $2.19 Million - $2.48 Million	54,488 Added 24.06%	280,996 $12.5 Million
Q2 2019 Aug 01, 2019	BUY	$37.28 - $41.68 $8.2 Million - $9.17 Million	220,023 Added 3392.8%	226,508 $9.35 Million
Q1 2019 Apr 30, 2019	SELL	$35.49 - $43.02 $60,723 - $73,607	-1,711 Reduced 20.88%	6,485 $262,000
Q4 2018 Feb 06, 2019	SELL	$36.86 - $41.49 $33,542 - $37,755	-910 Reduced 9.99%	8,196 $311,000
Q3 2018 Oct 29, 2018	SELL	$34.76 - $39.72 $695 - $794	-20 Reduced 0.22%	9,106 $360,000
Q2 2018 Jul 27, 2018	SELL	$34.55 - $37.05 $10,261 - $11,003	-297 Reduced 3.15%	9,126 $321,000
Q1 2018 May 11, 2018	BUY	$32.97 - $36.63 $310,676 - $345,164	9,423 New	9,423 $330,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $234B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.

Account

Cullen/Frost Bankers, Inc. Astrazeneca PLC Transaction History